Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Yescarta Side Effects Center
Medically reviewed by Min Clinic Staff | Updated: January 2026
- Generic Name: axicabtagene ciloleucel suspension for intravenous infusion
- Brand Name: YESCARTA
- Drug Class: CAR-T Cell Therapies
YESCARTA(Axicabtagene Ciloleucel Suspension for Intravenous Infusion) side effects drug center
Yescarta Side Effects Center
What Is Yescarta?
Yescarta (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma.
What Are Side Effects of Yescarta?
Common side effects of Yescarta include:
